Analyze Diet

Effects of toxic doses of phenylbutazone in ponies.

Abstract: Toxic doses of phenylbutazone (10 mg/kg of body weight) were administered to 10 ponies once daily for 14 days. Clinical signs of toxicosis similar to those seen in other species included CNS depression, anorexia, oral ulcers, and soft feces. Six ponies died in 7 to 20 days; 1 pony was euthanatized during an acute abdominal crisis; and 3 ponies survived the study. At necropsy, the major lesions were oral and gastrointestinal ulcerations and renal changes.
Publication Date: 1983-12-01 PubMed ID: 6660616
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the effects of toxic doses of a drug named phenylbutazone on ponies, and it shows that such doses can lead to serious health problems in ponies and even result in death.

Method and Subjects

  • The study involved 10 ponies that were given toxic doses of phenylbutazone. Phenylbutazone is a type of nonsteroidal anti-inflammatory drug.
  • The doses were administered once daily over a period of 14 days, and each dose was 10 mg/kg of the pony’s body weight.

Observations and Findings

  • Following the administration of the drug, the ponies exhibited clinical signs of toxicosis. This included symptoms such as CNS (central nervous system) depression, anorexia (loss of appetite), oral ulcers (sores in the mouth), and soft feces.
  • As a result of the toxicity, six out of the ten ponies died in a span of 7 to 20 days, and one pony had to be euthanatized due to an acute abdominal crisis. The remaining three ponies survived the study.

Necropsy Results

  • A necropsy (an autopsy for animals) was performed on the deceased ponies to understand the cause of death and the effects of the drug toxicity.
  • The major lesions found in the ponies were oral and gastrointestinal ulcerations (sores or injuries in the mouth and digestive tract) and renal changes (changes in the kidneys).

Conclusions

  • The study concludes that toxic doses of phenylbutazone can have severe health impacts on ponies, including damage to their digestive system and kidneys, and it may lead to death.

Cite This Article

APA
MacAllister CG. (1983). Effects of toxic doses of phenylbutazone in ponies. Am J Vet Res, 44(12), 2277-2279.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 44
Issue: 12
Pages: 2277-2279

Researcher Affiliations

MacAllister, C G

    MeSH Terms

    • Administration, Oral
    • Animals
    • Gastrointestinal Diseases / pathology
    • Gastrointestinal Diseases / veterinary
    • Horse Diseases / blood
    • Horse Diseases / pathology
    • Horses
    • Injections, Intravenous / veterinary
    • Mouth Diseases / pathology
    • Mouth Diseases / veterinary
    • Phenylbutazone / administration & dosage
    • Phenylbutazone / poisoning
    • Ulcer / pathology
    • Ulcer / veterinary

    Citations

    This article has been cited 8 times.
    1. Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis. Vet Med (Auckl) 2014;5:159-168.
      doi: 10.2147/VMRR.S70207pubmed: 32670856google scholar: lookup
    2. Worboys M, Toon E. Phenylbutazone (Bute, PBZ, EPZ): one drug across two species. Hist Philos Life Sci 2018 Mar 26;40(2):27.
      doi: 10.1007/s40656-018-0191-4pubmed: 29582183google scholar: lookup
    3. Galvin N, Dillon H, McGovern F. Right dorsal colitis in the horse: minireview and reports on three cases in Ireland. Ir Vet J 2004 Aug 1;57(8):467-73.
      doi: 10.1186/2046-0481-57-8-467pubmed: 21851661google scholar: lookup
    4. Silver K, Leloup L, Freeman LC, Wells A, Lillich JD. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. Int J Biochem Cell Biol 2010 Dec;42(12):2030-6.
      doi: 10.1016/j.biocel.2010.09.007pubmed: 20854926google scholar: lookup
    5. Kari F, Bucher J, Haseman J, Eustis S, Huff J. Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Jpn J Cancer Res 1995 Mar;86(3):252-63.
    6. Carrick JB, Papich MG, Middleton DM, Naylor JM, Townsend HG. Clinical and pathological effects of flunixin meglumine administration to neonatal foals. Can J Vet Res 1989 Apr;53(2):195-201.
      pubmed: 2713784
    7. van Galen G, Divers TJ, Savage V, Schott HC 2nd, Siwinska N. ECEIM consensus statement on equine kidney disease. J Vet Intern Med 2024 Jul-Aug;38(4):2008-2025.
      doi: 10.1111/jvim.17101pubmed: 38801172google scholar: lookup
    8. Tesena P, Vinijkumthorn R, Preuksathaporn T, Piyakul P, Chotikaprakal T, Sirireugwipas R, Wong-Aree K, Prapaiwan N. Evaluation of gastrointestinal tract lesions and serum malondialdehyde levels after repeated oral administration of phenylbutazone in horses. Vet Res Commun 2024 Aug;48(4):2343-2355.
      doi: 10.1007/s11259-024-10415-ypubmed: 38771448google scholar: lookup